Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

methylmercaptopurine riboside

A purine derivative with antineoplastic and anti-angiogenic properties. 6-methylmercaptopurine riboside (6-MMPR) inhibits amidophosphoribosyltransferase, the first committed step in de novo purine synthesis, and inhibits fibroblast growth factor-2 (FGF2)-induced cell proliferation.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:methylthioinosine
Abbreviation:6-MMPR
MMPR
Code name:NCI-C04784
SQ 21977
Chemical structure:6-(methylmercapto)purine ribonucleoside
6-(methylthio) inosine
6-(methylthio)purine ribonucleoside
6-(methylthio)purine riboside
6-methyl MP riboside
6-methylmercaptopurine riboside
6-methylthioinosine
9H-purine, 6-(methylthio)-9-beta-D-ribofuranosyl- (8CI 9CI)
9H-purine, 6-(methylthio)-9-beta-D-ribofuranosyl-, dihydrate
9H-purine, 6-(methylthio)-9beta-D-ribofuranosyl
beta-D-ribosyl-6-methylthiopurine
purine-6-thiol,6-methyl-9-ribofuranosyl
IND number:19524
2818
924
NSC code:40774
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search